-
ICD-10-CM Codes
›
-
C00-D49
›
-
C7B-C7B
›
-
C7B-
›
-
2023 ICD-10-CM Diagnosis Code C7B.01
2023 ICD-10-CM Diagnosis Code C7B.01
Secondary carcinoid tumors of distant lymph nodes
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- C7B.01 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2023 edition of ICD-10-CM C7B.01 became effective on October 1, 2022.
- This is the American ICD-10-CM version of C7B.01 - other international versions of ICD-10 C7B.01 may differ.
The following code(s) above
C7B.01 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
C7B.01:
Approximate Synonyms
- Carcinoid tumor metastatic to distant ln
- Neuroendocrine tumor metastatic to dist lymph node
- Secondary carcinoid tumor of distant lymph nodes
- Secondary neuroendocrine carcinoma of lymph node
ICD-10-CM C7B.01 is grouped within Diagnostic Related Group(s) (MS-DRG v40.0):
- 820 Lymphoma and leukemia with major o.r. Procedures with mcc
- 821 Lymphoma and leukemia with major o.r. Procedures with cc
- 822 Lymphoma and leukemia with major o.r. Procedures without cc/mcc
- 823 Lymphoma and non-acute leukemia with other procedures with mcc
- 824 Lymphoma and non-acute leukemia with other procedures with cc
- 825 Lymphoma and non-acute leukemia with other procedures without cc/mcc
- 840 Lymphoma and non-acute leukemia with mcc
- 841 Lymphoma and non-acute leukemia with cc
- 842 Lymphoma and non-acute leukemia without cc/mcc
Convert C7B.01 to ICD-9-CM
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
Code annotations containing back-references to C7B.01:
ICD-10-CM Codes Adjacent To C7B.01
C7A.093 Malignant carcinoid tumor of the kidney
C7A.094 Malignant carcinoid tumor of the foregut, unspecified
C7A.095 Malignant carcinoid tumor of the midgut, unspecified
C7A.096 Malignant carcinoid tumor of the hindgut, unspecified
C7A.098 Malignant carcinoid tumors of other sites
C7A.1 Malignant poorly differentiated neuroendocrine tumors
C7A.8 Other malignant neuroendocrine tumors
C7B Secondary neuroendocrine tumors
C7B.0 Secondary carcinoid tumors
C7B.01
…… of distant lymph nodes
C7B.1 Secondary Merkel cell carcinoma
C7B.8 Other secondary neuroendocrine tumors
C76 Malignant neoplasm of other and ill-defined sites
C76.0 Malignant neoplasm of head, face and neck
C76.1 Malignant neoplasm of thorax
C76.2 Malignant neoplasm of abdomen
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.